Status:
COMPLETED
Determining the Impact of Scaling up Mass Testing, Treatment and Tracking on Malaria Prevalence in Ghana
Lead Sponsor:
Noguchi Memorial Institute for Medical Research
Collaborating Sponsors:
Ghana National Malaria Control Programme
Communities
Conditions:
Malaria Asymptomatic Parasitaemia
Eligibility:
All Genders
2+ years
Phase:
NA
Brief Summary
Globally, malaria prevalence in 2016 was reported to have increased with 445,000 deaths, 91% of which occurred in sub-Sahara Africa with more than 75% being children. Individuals who carry the malaria...
Detailed Description
Background Malaria continues to pose a serious burden to the local populations in sub-Sahara Africa. Several efforts have been made to scale up interventions that work such as preventing man-vector co...
Eligibility Criteria
Inclusion
- Overall inclusion criteria for MTTT:
- Be aged 2 months or older
- Be resident in the study area
- Have completed and signed the consent for adults or assent form for children 12-17 years.
- Inclusion Criteria for children in the subgroup study:
- Be age range 6 months to 14 years
- Be resident in the study area for the period of the study.
- Be willing to participate
- Parent or guardian have completed and signed consent form
- Provided assent for children 12-17 years
Exclusion
- If an individual intents to stay less than one year in the study site
- Be absent at some time because he/she is schooling in a boarding school
- Has a life threatening illness (excluding malaria).
Key Trial Info
Start Date :
March 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 31 2023
Estimated Enrollment :
5861 Patients enrolled
Trial Details
Trial ID
NCT04301531
Start Date
March 1 2020
End Date
January 31 2023
Last Update
May 6 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Noguchi Memorial Institute for Medical Research
Accra, Greater, Ghana, +233